Metabolomic Profiling in Plants
Metabolomic profiling in plants is a powerful technique that enables the comprehensive analysis of metabolites within plant tissues. These small molecules, which include sugars, lipids, amino acids, and secondary metabolites, play crucial roles in plant growth, development, and responses to environmental stresses. By profiling metabolites, scientists can understand how plants respond to stressors such as drought, pathogens, or nutrient deficiencies. Advanced analytical tools like mass spectrometry and nuclear magnetic resonance are employed for accurate metabolite detection and quantification. This insight is invaluable for breeding programs aimed at developing more resilient plants with enhanced nutritional value or medicinal properties, making metabolomic profiling a key tool in plant biotechnology.
Srinivasa Rao Mentreddy
Alabama A&M University, United States
Mohammad Babadoost
University of Illinois, United States
Valasia Iakovoglou
UNESCO chair Con-E-Ect, International Hellenic University, Greece
Aparna B Gunjal
Dr. D.Y. Patil, Arts, Commerce and Science College, India
Anna Ponce
Bethune-Cookman University, United States
Hillary Jean Pierre
Department of Pharmaceutics, United States
Title : Biovalorization of overripe banana (Musa spp.) extract as a functional ingredient for glycemic regulation in diabesity management
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title :
Valasia Iakovoglou, UNESCO chair Con-E-Ect, International Hellenic University, Greece
Title : The antimicrobial activity of six Ocimum species against human microbial pathogens
Srinivasa Rao Mentreddy, Alabama A&M University, United States
Title : Effect of climate and weather on plant biology and biotechnology
Vijayan Gurumurthy Iyer, Techno-Economic-Environmental Study and Check Consultancy Services, India
Title : Cambial rearrangement in cycads: First evidence from a basal seed plant lineage
Anna Ponce, Bethune-Cookman University, United States
Title : Utilizing plant derived extracellular vesicles for drug delivery and therapeutic development
Hillary Jean Pierre, Department of Pharmaceutics, United States